Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Hodgkin’s Lymphoma Treatment Market Outlook

The global Hodgkin’s lymphoma treatment market reached a value of about USD 1.41 billion in 2023. The market is further estimated to grow at a CAGR of 13.20% in the forecast period of 2024-2032 to reach a value of around USD 4.31 billion by 2032.      

hodgkins lymphoma treatment market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Radiotherapy to Propel the Market Growth of Hodgkin’s Lymphoma Treatment

Based on the treatment type, the radiotherapy segment holds significant market share of Hodgkin’s lymphoma treatment. The growing awareness about the effectiveness of radiotherapy in killing Hodgkin’s lymphoma cells is contributing to the steady market growth. Radiotherapy is painless, and the treatment is administered in short sessions that require no hospital stay, thereby accelerating the market development. In addition, radiotherapy can be given along with surgery, chemotherapy, hormones, or targeted therapy, which offers the patients with wide choices to treat the disease completely, thus bolstering the market. The availability of modern imaging tests that enables the doctors to aim at the lymphoma sites precisely can help limit side effects, which plays a critical role in expanding the market for Hodgkin’s lymphoma treatment. The rising inclination of healthcare professionals towards newer approaches to radiation, such as Involved site radiation therapy (ISRT), which reduces the size of the treatment area and helps spare nearby normal tissues from getting radiation, is leading to the market growth of Hodgkin’s lymphoma treatment.

Market Segmentation

hodgkins lymphoma treatment market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hodgkin’s lymphoma is a type of cancer that spreads through the lymph vessels from lymph node to lymph node. The cancer in an advanced stage, though rarely, can invade the bloodstream and spread to other body parts, such as the liver, lungs, and bone marrow. There are two types of Hodgkin’s lymphoma - Classic Hodgkin lymphoma (cHL) and Nodular lymphocyte. The predominant treatments offered to cure the disease are chemotherapy, and radiotherapy, among others.

The market for Hodgkin’s lymphoma treatment, by treatment type, is divided into:

  • Chemotherapy
  • Radiotherapy
  • Others

The regional markets for Hodgkin’s lymphoma treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

hodgkins lymphoma treatment market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Worldwide Prevalence of Hodgkin’s Lymphoma to Drive the Market Growth of Hodgkin’s Lymphoma Treatment

The increasing prevalence of Hodgkin’s Lymphoma disease is leading to the market development of Hodgkin’s Lymphoma treatment. In 2019, about 218,740 people were living with Hodgkin lymphoma in the United States, and the region witnessed an estimated increase of 8,540 cases in 2023. The developing healthcare infrastructure and the rapid diagnosis of the disease are contributing to the market expansion of Hodgkin’s Lymphoma treatment. The growing awareness about the increased recovery chance of the disease among the people and the importance of treatments in it is further propelling the market for Hodgkin’s Lymphoma treatment. The government initiatives in approving novel drugs to treat Hodgkin’s Lymphoma play a critical role in expanding the market. In 2018, the U.S. FDA approved Adcetris (brentuximab vedotin) to treat adult patients with earlier untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy. The development of efficient therapies due to the research activities and the rising clinical trials is expected to augment the market for Hodgkin’s lymphoma treatment over the forecast period.

Key Players in the Global Hodgkin’s Lymphoma Treatment Market

The report gives a detailed analysis of the following key players in the global Hodgkin’s lymphoma treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Alkem Laboratories
  • Amneal Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • F Hoffmann-La Roche Ltd
  • Incyte Corp.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Region
Breakup by Treatment Type
  • Chemotherapy
  • Radiotherapy
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Alkem Laboratories
  • Amneal Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • F Hoffmann-La Roche Ltd
  • Incyte Corp.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global Hodgkin’s lymphoma treatment market attained a value of nearly USD 1.41 billion.

The market is assessed to grow at a CAGR of 13.20% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach almost USD 4.31 billion by 2032.

The major market drivers include the increased recovery chances through effective treatments, rapid diagnosis of the disease, developing healthcare infrastructure, and growing awareness about the different treatments available to cure the disease.

The key market trends include government initiatives in approving drugs, and research activities done to develop new therapies and drugs.

The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The various treatment types of Hodgkin’s lymphoma treatment, include chemotherapy, and radiotherapy, among others.

The major players in the market are Alkem Laboratories, Amneal Pharmaceuticals, Inc., Baxter International Inc., Biogen Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, and Incyte Corp., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124